FERMENTALG (ALGAE.PA) Stock Fundamental Analysis

EPA:ALGAE • FR0011271600

0.436 EUR
0 (0%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, ALGAE scores 3 out of 10 in our fundamental rating. ALGAE was compared to 66 industry peers in the Chemicals industry. ALGAE may be in some trouble as it scores bad on both profitability and health. ALGAE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ALGAE has reported negative net income.
  • In the past year ALGAE has reported a negative cash flow from operations.
  • In the past 5 years ALGAE always reported negative net income.
  • ALGAE had a negative operating cash flow in each of the past 5 years.
ALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • ALGAE has a Return On Assets of -24.56%. This is amonst the worse of the industry: ALGAE underperforms 87.88% of its industry peers.
  • Looking at the Return On Equity, with a value of -38.02%, ALGAE is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROIC N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ALGAE.PA Yearly ROA, ROE, ROICALGAE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 20.94%, ALGAE is doing worse than 68.18% of the companies in the same industry.
  • ALGAE's Gross Margin has declined in the last couple of years.
  • ALGAE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
ALGAE.PA Yearly Profit, Operating, Gross MarginsALGAE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ALGAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALGAE has been increased compared to 1 year ago.
  • The number of shares outstanding for ALGAE has been increased compared to 5 years ago.
  • ALGAE has a better debt/assets ratio than last year.
ALGAE.PA Yearly Shares OutstandingALGAE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALGAE.PA Yearly Total Debt VS Total AssetsALGAE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that ALGAE is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.32, ALGAE is doing worse than 75.76% of the companies in the same industry.
  • ALGAE has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.12, ALGAE is doing good in the industry, outperforming 77.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC6.22%
ALGAE.PA Yearly LT Debt VS Equity VS FCFALGAE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that ALGAE should not have too much problems paying its short term obligations.
  • ALGAE has a Current ratio (1.88) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.83 indicates that ALGAE should not have too much problems paying its short term obligations.
  • The Quick ratio of ALGAE (1.83) is better than 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.83
ALGAE.PA Yearly Current Assets VS Current LiabilitesALGAE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.44% over the past year.
  • Looking at the last year, ALGAE shows a very strong growth in Revenue. The Revenue has grown by 59.05%.
  • ALGAE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.52% yearly.
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.96% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 39.99% on average over the next years. This is a very strong growth
EPS Next Y30.77%
EPS Next 2Y30.09%
EPS Next 3Y27.59%
EPS Next 5Y17.96%
Revenue Next Year13.04%
Revenue Next 2Y50.36%
Revenue Next 3Y56.76%
Revenue Next 5Y39.99%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALGAE.PA Yearly Revenue VS EstimatesALGAE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ALGAE.PA Yearly EPS VS EstimatesALGAE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALGAE. In the last year negative earnings were reported.
  • Also next year ALGAE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGAE.PA Price Earnings VS Forward Price EarningsALGAE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALGAE.PA Per share dataALGAE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

  • ALGAE's earnings are expected to grow with 27.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.09%
EPS Next 3Y27.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALGAE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FERMENTALG

EPA:ALGAE (2/18/2026, 7:00:00 PM)

0.436

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-28
Earnings (Next)05-05
Inst Owners25.93%
Inst Owner ChangeN/A
Ins Owners2.02%
Ins Owner ChangeN/A
Market Cap39.17M
Revenue(TTM)12.78M
Net Income(TTM)-11.54M
Analysts84.44
Price Target0.66 (51.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.72%
PT rev (3m)-9.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.06
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.14
BVpS0.34
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.94%
FCFM N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.25%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.83
Altman-Z 1.32
F-Score6
WACC6.22%
ROIC/WACCN/A
Cap/Depr(3y)32.24%
Cap/Depr(5y)108.18%
Cap/Sales(3y)12.02%
Cap/Sales(5y)34.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
EPS Next Y30.77%
EPS Next 2Y30.09%
EPS Next 3Y27.59%
EPS Next 5Y17.96%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%
Revenue Next Year13.04%
Revenue Next 2Y50.36%
Revenue Next 3Y56.76%
Revenue Next 5Y39.99%
EBIT growth 1Y15.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.18%
EBIT Next 3Y33.56%
EBIT Next 5Y22.54%
FCF growth 1Y49.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.34%
OCF growth 3YN/A
OCF growth 5YN/A

FERMENTALG / ALGAE.PA FAQ

What is the ChartMill fundamental rating of FERMENTALG (ALGAE.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALGAE.PA.


What is the valuation status for ALGAE stock?

ChartMill assigns a valuation rating of 1 / 10 to FERMENTALG (ALGAE.PA). This can be considered as Overvalued.


Can you provide the profitability details for FERMENTALG?

FERMENTALG (ALGAE.PA) has a profitability rating of 0 / 10.